Physiological Effects of New Polyphenol-enriched Foods in Humans
Study Details
Study Description
Brief Summary
Polyphenolic compounds exert several health benefits depending on bioavailability. Encapsulation may improve bioavailability of these compounds.This study will evaluate bioavailability of some polyphenols (curcumin and cocoa polyphenols) from new enriched-foods. In particular bread and nut based creams will be used as food matrices to include free or encapsulated polyphenols.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Polyphenolic compounds are abundant in foods and have been suggested to exert several health benefits including prevention of cancer, cardiovascular disease, suppressing inflammation, diabetes, etc. These properties are mediated by bioavailability of individual polyphenols that is, in turn, influenced by food properties (food matrix, technological processing, etc.), interaction with other compounds, and host related factors. Some well-studied dietary polyphenols include catechins from tea, curcumin from turmeric, procyanidins and anthocyanidins in grapes, berries, and dark chocolate. These compounds have strong antioxidative activities in vitro and have been suggested to have several beneficial health effects.
Curcumin, a phenolic compound deriving from turmeric spice, shows many biological and pharmacological effects, and clinical studies in humans proved that it's extremely safe and well tolerated even at very high doses (8-12 g/day). However, curcumin has not yet been approved as a therapeutic agent, because of its very low bioavailability depending on a poor absorption, rapid metabolism and rapid systemic clearance. Different approaches have been investigated to improve curcumin bioavailability. Among them, the use of adjuvants that interferes with metabolic pathways of curcumin, like piperine, represents one of the main strategies used to enhance its bioavailability. A further approach consists on manufacturing of curcumin containing liposomes, phospholipids complexes or nanoparticles. For polymer-based nanoparticles, maintenance of biological activity, increased absorption and delayed delivery was reported.
Cocoa based products are widely consumed in many countries, and indications of health benefits by some cocoa constituents, mainly polyphenols, have also been reported. Cocoa contains very high levels of polyphenols, in particular flavanols and among these, mainly epicatechins. The bioavailability of cocoa polyphenols has been measured in several human studies from acute consumption of cocoa rich beverages or chocolate. Monomeric flavonoids as well as dimeric and trimeric procyanidins were detected in human plasma over 2-3 hours from consumption. Plasma concentration of cocoa polyphenols were often in the nanomolar or low micromolar range. Donovan and coworkers demonstrated that commercial available chocolate samples contain a predominance of the less bioavailable (-)-catechin enantiomer as compared to the (+)-catechin which is present in most other plant derived foods. This may explain the relatively low bioavailability of catechins from chocolate and cocoa-containing products. The food matrix seems to be an important factor that may affect the bioavailability of cocoa polyphenols. For instance, proteins in the food matrix are supposed to form highly polymerized complexes with procyanidins, which can reduce bioaccessibility of these phenolic compounds. However, the potential negative effect of protein content in foods was not confirmed in a study that evaluated the cocoa polyphenols bioavailability after the intake of a milk-powder cocoa beverage. However, concurrent carbohydrates consumption seems to increase significantly the uptake of flavonols in humans. Little is known whether and to what extent oligomeric procyanidins from cocoa are absorbed. However, the biological activity of procyanidins with high polymerization degree may be partly attributed to their colonic breakdown products, including phenolic acids.
Actually there is also a growing interest in other biological properties of phenolic compounds in addition to their antioxidant effects; particularly, some evidences suggest that certain dietary phenols may modulate metabolic homeostasis. This is the case of chlorogenic acids, that are reported to play a potential role in modifying the pattern of intestinal glucose uptake and of other flavonoids (quercetin, catechins) that may modulate activation of GLP-1 receptor, involved in modulation of insulin and glucagon secretion, gastric emptying, and appetite.
In this randomized, crossover trial, serum, urine and fecal concentrations of curcumin and cocoa polyphenols, their parental compounds, metabolites and phenolic acids, following a two day multi-dose administration with six food sources, will be measured. All volunteers will undergo to six interventions - bread enriched with three different forms of curcumin (free, encapsulated, and encapsulated plus piperine) and nut based creams enriched with cocoa polyphenols (free or encapsulated one) or control cream (without enrichment). A one-week wash-out period will be included between two sequential treatments. Blood, urine and feces will be collected at time 0 (baseline), 24, and 48 hours; further blood samples at 0.5, 1, 2, 4, 6 hours after consumption of the first meal, and urine samples at 2 hours time intervals up to 10 hours, will be collected too. In particular, area under the curve (AUC) of serum and urine concentrations of parental compounds and metabolites in the time interval 0-24 hours will be calculated as primary outcomes. In addition the amount of total polyphenols in fecal samples will be measured.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: encapsulated curcumin
|
Other: encapsulated curcumin
encapsulated curcumin-enriched bread, 1g/100g bread, 200g bread/day
|
Experimental: encapsulated curcumin + PQG PQG means Piperine, Quercetin and Genistein |
Other: encapsulated curcumin + PQG
bread enriched with encapsulated curcumin plus piperine, quercetin and genistein, 1g/100g bread, 200g bread/day
|
Active Comparator: free cocoa polyphenol
|
Other: free cocoa polyphenol
nut cream enriched with free cocoa polyphenols, 1,5 g/100g cream, 100g/day per 1 day
|
Placebo Comparator: control
|
Other: control nut cream
nut cream, cocoa polyphenols 0g/100g cream, 100 g/day per 1 day
|
Experimental: encapsulated cocoa polyphenols
|
Other: encapsulated cocoa polyphenols
nut cream enriched with encapsulated cocoa polyphenols, 1,5 g/100g cream, 100g/day per 1 day
|
Active Comparator: free curcumin Subjects will consume bread added with free curcumin |
Other: free curcumin
free curcumin in bread, dosage 1g/100g, 200g/day per 1 day
|
Outcome Measures
Primary Outcome Measures
- Serum Polyphenol Concentrations Over 24h From Food Consumption [0, 0.5, 1, 2, 4, 6, and 24 hours post-dose]
Area Under the Curves (AUC) from 0 to 24h of parent polyphenols was calculated using a trapezoidal rule applied to the concentration-time curves of compounds.
- Urinary Excretion of Total Polyphenols [Time intervals: 0-2, 2-4, 4-6, 6-8, 10-24 hours post-dose.]
Area Under the Curve (AUC) from 0 to 24h of total polyphenols (sum of parent polyphenols and metabolites)was calculated using a trapezoidal rule applied to the urinary concentration-time curves of compounds.
- Amount of Total Fecal Polyphenols [0 and 24 hours post-dose.]
Amount of parent polyphenols and metabolites in feces was calculated by multiplying net concentrations by the amount of feces.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 - 45 years old, male and female
-
Healthy by medical assessment
-
Normal weight: BMI 18 - 25
-
Sign of a written informed consent
Exclusion Criteria:
-
Age > 18 and < 45 years old
-
Pregnancy or breastfeeding
-
Intestinal or metabolic diseases/disorders such as diabetic, renal, hepatic, hypertension, pancreatic or ulcer, including lactose-intolerance
-
Previous abdominal/gastrointestinal surgery
-
Regular consumption of medication
-
Antibiotic therapy within 2 months previous the study
-
Food allergies and intolerances (celiac disease, lactose intolerance, nut allergy etc)
-
Unwilling to consume experimental foods
-
Concurrent participation or having participated to another clinical trial during the last 3 weeks
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Food Science | Portici | Italy | 80055 |
Sponsors and Collaborators
- Federico II University
Investigators
- Principal Investigator: Vincenzo Fogliano, Professor, University of Naples
- Study Director: Paola Vitaglione, Researcher, University of Naples
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- DSA-FF-01
Study Results
Participant Flow
Recruitment Details | The recruitment was performed at the ambulatory of Department of Food Science (University of Naples) among students of Agriculture Faculty. It began on December 2010 up to February 2011. |
---|---|
Pre-assignment Detail | Subjects were enrolled after signing a Consent Form and were randomized to the treatments. All subjects enrolled completed the study. |
Arm/Group Title | Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control Cream | Encapsulated Cocoa Polyphenols | Free Curcumin |
---|---|---|---|---|---|---|
Arm/Group Description | Subjects consumed 2 bread portions/day of bread enriched with micro-encapsulated curcumin(1g/100g portion, i.e. 2g/day) | Subjects consumed 2 bread portions/day of bread enriched with micro-capsules containing curcumin at dosage of 1 g/100 g plus 0.1% of Piperine, Quercetin and Genistein (PQG) (2g curcumin + 0.2g PQG/day) for one day. | Subjects consumed 3 nut cream portions (33g each) enriched with cocoa polyphenols at dosage of 1.5g/day. | Subjects consumed 3 nut cream portions (33g each). | Subjects consumed 3 nut cream portions (33g each) enriched with encapsulated cocoa polyphenols at dosage of 1.5g/day. | Subjects consumed 2 portions of bread enriched with free curcumin (1g/100g portion, i.e. 2g/day) |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 5 | 0 | 0 | 0 | 0 | 5 |
COMPLETED | 5 | 0 | 0 | 0 | 0 | 5 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 5 | 0 | 0 | 0 | 0 | 5 |
COMPLETED | 5 | 0 | 0 | 0 | 0 | 5 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 5 | 0 | 0 | 0 | 0 | 5 |
COMPLETED | 5 | 0 | 0 | 0 | 0 | 5 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 5 | 0 | 0 | 0 | 0 | 5 |
COMPLETED | 5 | 0 | 0 | 0 | 0 | 5 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 5 | 5 | 0 | 0 | 0 |
COMPLETED | 0 | 5 | 5 | 0 | 0 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 5 | 5 | 0 | 0 | 0 |
COMPLETED | 0 | 5 | 5 | 0 | 0 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 5 | 5 | 0 | 0 | 0 |
COMPLETED | 0 | 5 | 5 | 0 | 0 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 0 | 0 | 5 | 5 | 0 |
COMPLETED | 0 | 0 | 0 | 5 | 5 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 0 | 0 | 5 | 5 | 0 |
COMPLETED | 0 | 0 | 0 | 5 | 5 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 0 | 0 | 5 | 5 | 0 |
COMPLETED | 0 | 0 | 0 | 5 | 5 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Period Title: Free Then Encapsulated Curcumin (1 Day) | ||||||
STARTED | 0 | 0 | 0 | 5 | 5 | 0 |
COMPLETED | 0 | 0 | 0 | 5 | 5 | 0 |
NOT COMPLETED | 0 | 0 | 0 | 0 | 0 | 0 |
Baseline Characteristics
Arm/Group Title | All Study Participants |
---|---|
Arm/Group Description | All participants followed all the periods |
Overall Participants | 10 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
10
100%
|
>=65 years |
0
0%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
31
(2)
|
Sex: Female, Male (Count of Participants) | |
Female |
5
50%
|
Male |
5
50%
|
Region of Enrollment (participants) [Number] | |
Italy |
10
100%
|
Outcome Measures
Title | Serum Polyphenol Concentrations Over 24h From Food Consumption |
---|---|
Description | Area Under the Curves (AUC) from 0 to 24h of parent polyphenols was calculated using a trapezoidal rule applied to the concentration-time curves of compounds. |
Time Frame | 0, 0.5, 1, 2, 4, 6, and 24 hours post-dose |
Outcome Measure Data
Analysis Population Description |
---|
The number of subjects was based on power calculations derived from our previous study. We calculated that, at α = 0.05 with a power of 80%, 8 subjects would allow us to detect a 20% difference in serum and urinary concentrations of parental compounds, glucuronides and phenolic acids. |
Arm/Group Title | Free Curcumin | Encapsulated Curcumin | Encapsulated Curcumin + PQG | Control Cream | Free Cocoa Polyphenols | Encapsulated Cocoa Polyphenols |
---|---|---|---|---|---|---|
Arm/Group Description | subjects consumed bread enriched with free curcumin | subjects consumed bread enriched with encapsulated curcumin | subjects consumed bread enriched with encapsulated curcumin plus piperine, quercetin and genistein | subjects consumed cocoa-nut cream | subjects consumed cocoa-nut cream enriched with cocoa polyphenols in the free form | subjects consumed cocoa-nut cream enriched with encapsulated cocoa polyphenols |
Measure Participants | 10 | 10 | 10 | 10 | 10 | 10 |
Mean (Standard Error) [nmol*h/L] |
1.7
(0.1)
|
12.1
(1.1)
|
7.7
(1.8)
|
0.01
(0.00)
|
7.3
(0.9)
|
0.5
(0.1)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Free Curcumin, Encapsulated Curcumin, Encapsulated Curcumin + PQG, Control Cream, Free Cocoa Polyphenols, Encapsulated Cocoa Polyphenols |
---|---|---|
Comments | ||
Type of Statistical Test | Non-Inferiority or Equivalence | |
Comments | The results from LC-MS/MS analysis of parent polyphenols were analyzed and expressed as the absolute changes from the baseline to reduce possible effects of inter-subject fasting variability | |
Statistical Test of Hypothesis | p-Value | 0.02 |
Comments | ||
Method | ANOVA | |
Comments | ||
Method of Estimation | Estimation Parameter | Mean Difference (Final Values) |
Estimated Value | 1 | |
Confidence Interval |
(2-Sided) 95% to |
|
Parameter Dispersion |
Type: Standard Error of the Mean Value: 0.1 |
|
Estimation Comments |
Title | Urinary Excretion of Total Polyphenols |
---|---|
Description | Area Under the Curve (AUC) from 0 to 24h of total polyphenols (sum of parent polyphenols and metabolites)was calculated using a trapezoidal rule applied to the urinary concentration-time curves of compounds. |
Time Frame | Time intervals: 0-2, 2-4, 4-6, 6-8, 10-24 hours post-dose. |
Outcome Measure Data
Analysis Population Description |
---|
Basing on power analysis calculation on a previous work |
Arm/Group Title | Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control | Encapsulated Cocoa Polyphenols | Free Curcumin |
---|---|---|---|---|---|---|
Arm/Group Description | subjects consumed bread containing encapsulated curcumin | subjects consumed bread containing encapsulated curcumin plus PQG (i.e. Piperine, Quercetin and Genistein) | subjects consumed nut creams added with cocoa polyphenols | Subjects consumed white bread or nut cream | subjects consumed nut creams added with encapsulate cocoa-polyphenols | Subjects consumed bread added with free curcumin |
Measure Participants | 10 | 10 | 10 | 10 | 10 | 10 |
Mean (Standard Error) [nmol•h/L] |
2.0
(0.8)
|
2.21
(1.27)
|
9.67
(6.7)
|
19.1
(12.3)
|
4.92
(3.36)
|
1.31
(0.81)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Free Curcumin, Encapsulated Curcumin, Encapsulated Curcumin + PQG, Control Cream, Free Cocoa Polyphenols, Encapsulated Cocoa Polyphenols |
---|---|---|
Comments | Statistical analysis was performed using the statistical package SPSS for Windows (version15). By the analysis of variance (ANOVA) for repeated measures the subjective time curves for all measured compounds were compared and tested for the effect of treatment and of time as factors. For all tests, following a significant main effect in the ANOVA, individual means were compared using the Bonferroni test (p < 0.05). Results were considered significant at p < 0.05. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.01 |
Comments | ||
Method | ANOVA | |
Comments | ||
Method of Estimation | Estimation Parameter | Mean Difference (Final Values) |
Estimated Value | 0.9 | |
Confidence Interval |
(2-Sided) 95% to |
|
Parameter Dispersion |
Type: Standard Error of the Mean Value: 0.01 |
|
Estimation Comments |
Title | Amount of Total Fecal Polyphenols |
---|---|
Description | Amount of parent polyphenols and metabolites in feces was calculated by multiplying net concentrations by the amount of feces. |
Time Frame | 0 and 24 hours post-dose. |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control | Encapsulated Cocoa Polyphenols | Free Curcumin |
---|---|---|---|---|---|---|
Arm/Group Description | subjects consumed bread containing encapsulated curcumin | subjects consumed bread containing encapsulated curcumin plus PQG (i.e. Piperine, Quercetin and Genistein) | subjects consumed nut creams added with cocoa polyphenols | Subjects consumed white bread or nut cream | subjects consumed nut creams added with encapsulate cocoa-polyphenols | Subjects consumed bread added with free curcumin |
Measure Participants | 10 | 10 | 10 | 10 | 10 | 10 |
Mean (Standard Error) [nmol] |
3.49
(2.13)
|
0.49
(0.01)
|
27.98
(13.97)
|
4.27
(4.52)
|
150.97
(54.65)
|
0.59
(0.38)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Free Curcumin, Encapsulated Curcumin, Encapsulated Curcumin + PQG, Control Cream, Free Cocoa Polyphenols |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.04 |
Comments | ||
Method | ANOVA | |
Comments | ||
Method of Estimation | Estimation Parameter | Mean Difference (Final Values) |
Estimated Value | 0.2 | |
Confidence Interval |
(2-Sided) 95% to |
|
Parameter Dispersion |
Type: Standard Error of the Mean Value: 0.01 |
|
Estimation Comments |
Adverse Events
Time Frame | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||||||||
Arm/Group Title | Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control Cream | Encapsulated Cocoa Polyphenols | Free Curcumin | ||||||
Arm/Group Description | Subjects consumed 2 bread portions/day of bread enriched with micro-encapsulated curcumin(1g/100g portion, i.e. 2g/day) | Subjects consumed 2 bread portions/day of bread enriched with micro-capsules containing curcumin at dosage of 1 g/100 g plus 0.1% of Piperine, Quercetin and Genistein (PQG) (2g curcumin + 0.2g PQG/day) for one day. | Subjects consumed 3 nut cream portions (33g each) enriched with cocoa polyphenols at dosage of 1.5g/day. | Subjects consumed 3 nut cream portions (33g each). | Subjects consumed 3 nut cream portions (33g each) enriched with encapsulated cocoa polyphenols at dosage of 1.5g/day. | Subjects consumed 2 portions of bread enriched with free curcumin (1g/100g portion, i.e. 2g/day) | ||||||
All Cause Mortality |
||||||||||||
Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control Cream | Encapsulated Cocoa Polyphenols | Free Curcumin | |||||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | / (NaN) | / (NaN) | / (NaN) | / (NaN) | ||||||
Serious Adverse Events |
||||||||||||
Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control Cream | Encapsulated Cocoa Polyphenols | Free Curcumin | |||||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | ||||||
Other (Not Including Serious) Adverse Events |
||||||||||||
Encapsulated Curcumin | Encapsulated Curcumin + PQG | Free Cocoa Polyphenol | Control Cream | Encapsulated Cocoa Polyphenols | Free Curcumin | |||||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Prof. Vincenzo Fogliano |
---|---|
Organization | University of Naples |
Phone | +39 0812539356 |
fogliano@unina.it |
- DSA-FF-01